AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+22.25%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.52B
AUM Growth
+$4.52B
(+17%)
Cap. Flow
-$931K
Cap. Flow
% of AUM
-0.02%
Top 10 Holdings %
Top 10 Hldgs %
91.49%
Holding
100
New
10
Increased
15
Reduced
23
Closed
3
Top Buys
| 1 |
Goldman Sachs
GS
|
$22.2M |
| 2 |
Neurocrine Biosciences
NBIX
|
$10.4M |
| 3 |
MDCO
Medicines Co
MDCO
|
$9.5M |
| 4 |
Incyte
INCY
|
$9.44M |
| 5 |
Nektar Therapeutics
NKTR
|
$7.82M |
Top Sells
| 1 |
Alibaba
BABA
|
$27M |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
$12.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$6.81M |
| 4 |
SAGE
Sage Therapeutics
SAGE
|
$6.77M |
| 5 |
ZTO Express
ZTO
|
$6.28M |
Sector Composition
| 1 | Consumer Staples | 44.29% |
| 2 | Healthcare | 31.71% |
| 3 | Consumer Discretionary | 21.77% |
| 4 | Financials | 0.83% |
| 5 | Industrials | 0.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BUFF
1
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $1.99B | 34.85% | 87,460,875 | – | – |
|
|
WW
2
DELISTED
WW International
WW
| $984M | 17.19% | 29,443,300 | – | – |
|
3
Lexicon Pharmaceuticals
LXRX
$400M
| $946M | 16.53% | 57,517,977 | – | – |
|
|
4
Incyte
INCY
$16.5B
| $50.4M | 0.88% | 400,000 +75,000 | +23% | +$9.44M |
|
5
Agios Pharmaceuticals
AGIO
$2.19B
| $36M | 0.63% | 700,000 -50,000 | -7% | -$2.57M |
|
|
6
Nektar Therapeutics
NKTR
$568M
| $27.4M | 0.48% | 1,400,000 +400,000 | +40% | +$7.82M |
|
|
BLUE
7
DELISTED
bluebird bio
BLUE
| $26.3M | 0.46% | 250,000 | – | – |
|
|
8
Neurocrine Biosciences
NBIX
$13.8B
| $25.3M | 0.44% | 550,000 +225,000 | +69% | +$10.4M |
|
|
9
BioMarin Pharmaceuticals
BMRN
$11.2B
| $22.7M | 0.4% | 250,000 -75,000 | -23% | -$6.81M |
|
|
10
Goldman Sachs
GS
$226B
| $22.2M | 0.39% | +100,000 | New | +$22.2M |
|
11
Alnylam Pharmaceuticals
ALNY
$58.5B
| $21.9M | 0.38% | 275,000 -25,000 | -8% | -$1.99M |
|
|
XLRN
12
DELISTED
Acceleron Pharma Inc.
XLRN
| $21.3M | 0.37% | 700,000 -50,000 | -7% | -$1.52M |
|
|
ONC
13
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $18M | 0.31% | 400,000 +36,714 | +10% | +$1.65M |
|
14
Amicus Therapeutics
FOLD
$2.34B
| $14.1M | 0.25% | 1,400,000 -500,000 | -26% | -$5.04M |
|
|
MDCO
15
DELISTED
Medicines Co
MDCO
| $13.3M | 0.23% | 350,000 +250,000 | +250% | +$9.5M |
|
|
ALXN
16
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $12.2M | 0.21% | 100,000 | – | – |
|
17
Ironwood Pharmaceuticals
IRWD
$214M
| $11.6M | 0.2% | 616,879 -100,000 | -14% | -$1.89M |
|
|
AVXS
18
DELISTED
AveXis, Inc. Common Stock
AVXS
| $11.5M | 0.2% | 140,000 +20,000 | +17% | +$1.64M |
|
|
KITE
19
DELISTED
Kite Pharma, Inc.
KITE
| $10.4M | 0.18% | 100,000 -30,000 | -23% | -$3.11M |
|
|
ATH
20
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $9.92M | 0.17% | 200,000 -250,000 | -56% | -$12.4M |
|
|
RXDX
21
DELISTED
Ignyta, Inc.
RXDX
| $9.32M | 0.16% | 900,000 -37,000 | -4% | -$383K |
|
|
HZNP
22
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $9.02M | 0.16% | 760,000 -40,000 | -5% | -$475K |
|
|
ARRY
23
DELISTED
Array Biopharma Inc
ARRY
| $7.95M | 0.14% | 950,000 +200,000 | +27% | +$1.67M |
|
|
AGEN
24
Agenus
AGEN
$133M
| $7.82M | 0.14% | 2,000,000 -200,000 | -9% | -$782K |
|
|
SAGE
25
DELISTED
Sage Therapeutics
SAGE
| $7.17M | 0.13% | 90,000 -85,000 | -49% | -$6.77M |
|